FZD4 and non-small cell lung carcinoma: TCGA data mining showed that NSCLC patients with higher FZD4 expression had increased overall survival compared to patients with lower FZD4 expression (Fig. 6E), coinciding with similar correlation between FOXF1 and patient survival (Fig. 1D).